ÃâÒßѧÊÔÌâ
WKfkKk;G Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
WJH\~<{mP 1. Fas(CD95)/FasL
PNs~[ 2. common chain of cytokine receptor
]}|byo 3 . TCR/CD3 complex
tBbOY}.VD 4. negaive selection of thymocytes
'a6<ixgo0 5. artificial active immune
ED>prE0 6. anti-idiotypic
D\dWt1n 7. IgSF
:KJ pk:< 8. Integrin
u$#Wv2| mk 9. chemokine
RD7^& 10. B7/CD28
Hmt^h(*/2 ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£©
|1b_*G4| 1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£
IYn]U4P.
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£
Q_-_^J 3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ 4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
l/TjQ* 5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½
t7n(Qkrv
9vUO*D 1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£
hI%bjuq µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ
7w,FX.=;cv Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£©
y&}E~5O 1. B7/CD28
Vtc36-\1* 2. Th1 subset
"k*PA\U 3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£©
Nkxmm/Z 4. antibody affinity maturation
_vSn` 5. AP-1
?0?
R 6. single chain variable fragment£¨ScFv£©
L
pR''`2BT 7. NK cell receptor
5^']+5_vb 8. Zinkernagel-Doherty phenomenon
+a-6Q ~ 9. Ig fold
{ eCC$&" 10. CD40/CD40L
?]D"k4 ¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£©
.CL^BiD.D 1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£
;};wq&b# 2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿
6qcO?U 3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿
pw7[y^[Qg Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩
f$NM M
>z 1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£
^Ge+~o?x 2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£
i4^o59}8 3. ÊÔÊöÖ×ÁöÒßÃçµÄÑо¿½øÕ¹¡££¨Ïû»¯ÄÚ¿Æ×¨Òµ£©¡£
-S3MH1TZ Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
:0s]U_h £¨ÃâÒßѧרҵºÍרҵ»ù´¡£©
^Z~;4il_F Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£©
f B9;_z 1.Co-stimulators (or co-stimulating molecules)
yAoe51h? 2.NK-kB
.e_cgad : 3.Immunoglobulin superfamily
y|'SXM 4.antigen-presenting cell (APC)
LX^u_Iu 5.death domain
Me
5_4H&Sg 6.CCR and CXCR
r*Yi1j/ 7.Lectin (or mitogen)
fk_o@
G!0 8.Clusters of differentiation, CD)
_YF%V;X 9.B7 family
e^.Fa59 10.Cytotoxic T lymphocyte, CTL)
P2bZ65>3y 11.IL-15 and IL-15 receptor (IL-15R)
:=J,z,H_U 12.MHC restriction
6`f2-f9%iq 13.Affinity-chromatography
N!g9*Z 14.Cyctosprin A, CsA
9W(dmde> 15.Antibody-dependent cell-mediated cytotoxicity, ADCC)
V0)fZS@tf ¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£©
{GC?SaK 1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿
9uGrk^<t 2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£
$
sEy%- 3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£
?Wz8[u Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£©
L'F
<ev ÃâÒßѧרҵ£º
j$+nKc$ 1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£
:s4p/*f Ïû»¯ÄÚ¿Æ£º
@HOBRRm` 2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£
#5f-`~^C{ ѪҺ²¡Ñ§×¨Òµ£º
f"<O0Qw 3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿
,v{rCxFtvU Ò»¾Å¾ÅÄê¾Å²©Ê¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
}K&7%N4LZ (רҵ»ù´¡: ÃâÒßѧ)
1PpyV f Ò».Ãû´Ê½âÊÍ(ÿÌâ5·Ö,¹²45·Ö)
\_lod kf 1. ADCC(antibody dependent cell-mediated cytotoxicity)
0zi~p>*nJC 2. »·æß¾úËØ(cyclosporin)
sQ
fFu 3. KIR(killer cell inhibitory receptor)
8?%-'z. 4. HLDA(human leucocyte differentiation antigen)
<WcR,d 5. Interleukin 18(IL-18)
}5hqDBK? 6. ÕûºÏËØ(integrin)
,gS;m
&!'J 7. Fas/FasL
ypy
68_xyW 8. FcR(ÃâÒßÇòµ°°×Fc¶ÎÊÜÌå)
;A*`e$ 9. ϸ°û¼äÕ³¸½·Ö×Ó(ICAM)
v-PXZ'7~ 10. Th1/Th2
kOed ]>H 11. »ùÒòÒßÃç(DNAÒßÃç)
^pYxKU_O 12. chemokines and chemokine receptor
#*
KNPh 13. ÃâÒßÄÍÊÜ
w'UVKpG+ 14. ¹²´Ì¼¤·Ö×Ó
@0F3$ 15. ËÀÍö½á¹¹Óò(death domain)
RS^lKJ1 U ¶þ.ÎÊ´ðÌâ(µÚ1¡¢2Ìâ¸÷18·Ö,µÚ3Ìâ19·Ö)
ROous4 MG 1. ÊԱȽÏɱÉËÐÔTϸ°û(CTL)Óë×ÔȻɱÉËϸ°û(NK)ÔÚɱÉ˰Ðϸ°û¹ý³ÌÖÐ,ʶ±ðϸ°û¶¾¼°½éµ¼ÃâÒß¹¦ÄÜÓкβ»Í¬?
2'W<h)m)z 2. 70Äê´úÒÔÀ´,ÓйØIgºÍÌåÒºÃâÒßÑо¿´æÔÚÒÔϼ¸ÏîÖØ´ó·¢ÏÖºÍÍ»ÆÆ¶ø»ñµÃҽѧºÍÉúÎïѧŵ±´¶û½±,Çë·Ö±ð²ûÊöËüÃǵÄÀíÂÛÒâÒå¼°ÔÚҽѧʵ¼ùÖеÄÓ¦Óá£
1 A\OC £¨1£©1972Ä꣺θµ°°×øºÍľ¹Ïµ°°×øˮ½âIg£¬»ñµÃFab¡¢Fc¡¢F£¨ab¡¯£©2µÈƬ¶Î
oomT)gO 6* £¨2£©1977Ä꣺·ÅÉäÃâÒß·¨
m_)FC-/pSl £¨3£©1984Ä꣺ÁܰÍϸ°ûÔÓ½»ÁöºÍµ¥¿Ë¡¿¹Ìå
yI"6Da6|y £¨4£©1987Äê: Ig»ùÒòµÄ½á¹¹
z[3L2U~6 3. ½üÄêÀ´ÔÚÖ×ÁöÃâÒßÑо¿ÁìÓòÖÐÓÐÄÄÐ©ÖØÒª½øÕ¹?ÊÔÊöµ±Ç°Ìá¸ß»úÌ忹Ö×ÁöÃâÒßµÄÖ÷Òª²ßÂÔ¡£
BYMi6wts Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(ÃâÒßѧרҵ)
m+Rv+_R ÎÊ´ðÌâ(ÿÌâ25·Ö)
CL+}|7O( 1. ÊԱȽÏTϸ°ûÊÜÌ壨TCR£©¡¢Bϸ°ûÊÜÌ壨BCR£©ºÍNKϸ°ûÊÜÌ壨NKCR£©µÄ×é³É£¬Ê¶±ðÅäÌåÒÔ¼°ÐźÅתµ¼µÄÒìͬµã¡£
hBBUw0" 2. ÒÔÐØÏÙÒÀÀµ¿¹Ô´Ì¼¤»úÌå²úÉú¿¹ÌåµÄÃâÒßÓ¦´ðΪÀý£¬Tϸ°ûºÍBϸ°ûÊÇÈçºÎÏ໥×÷Óã¿ÓÐÄÄЩճ¸½·Ö×Ӻ͹²´Ì¼¤·Ö×Ó²ÎÓëT¡¢Bϸ°ûµÄÏ໥×÷Óã¿
5Er2}KZJv, 3. Éö×ÛºÏÕ÷³öѪÈÈ(HFRS)²¡¶¾µÄ½á¹¹»ùÒòÒѾ¸ãÇå³þ,ΪÁË֤ʵHFRS²¡¶¾¸ÐȾ»úÌå(ÒÔBalb/CСÊóΪÀý)¿É²úÉúHFRS²¡¶¾ºËÒ¿ǵ°°×(NP)ÌØÒìÐÔCTL,²¢ÔÚÃâÒß·À»¤ÖÐÆðÖØÒª×÷ÓÃ,ÇëÓ¦ÓÃÃâÒßѧÀíÂۺͷ½·¨,Éè¼ÆÒ»ÏµÍ³ÊµÑé,¼ÓÒÔ֤ʵ¡£
|v$JCU3!A 4. Àý¾Ù¶þ¸ö½üÄêÀ´Ï¸°ûºÍ·Ö×ÓÃâÒßѧÑо¿ÖгöÏÖµÄеÄÈȵã,Çë·Ö±ðÆÀÊöÆäÑо¿ÒâÒå¡¢·¢Õ¹Ç÷ÊÆÒÔ¼°Ó¦ÓÃǰ¾°¡£